How Does Genetic Heterogeneity Affect Disease Risk Assessment?
Genetic heterogeneity complicates disease risk assessment as different mutations might confer varying levels of risk. For example, in breast cancer, mutations in both the BRCA1 and BRCA2 genes can increase risk, but the degree of risk and treatment options may differ. Epidemiologists must consider these nuances when designing studies and interpreting data.
